Page 1
Design, synthesis, anticancer activities of novel 2-amino-4-
phenylthiazole scaffold containing amide moieties
Zhi-Hua Zhang,a Hong-Mei Wu,a Sai-Nan Deng,b Xiao-Yu Cai,b Yu Yao,b Muriira Cyrus Mwenda,b Jin-Yin Wang, b Dong Cai, *,c Yu Chen, *,d
a School of Chemical and Environmental Engineering, Liaoning University of Technology, Jinzhou,121001, China; bCollege of Pharmacy, Jinzhou Medical University, Jinzhou, 121001, China ; cCollege of Public Basic Sciences , Jinzhou Medical University, Jinzhou, 121001, China; and d School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Page 2
3-methyl-N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)benzamide 5a:
Page 3
3,4-dichloro-N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)benzamide 5b:
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.011.512.012.513.0f1 (ppm)
3.81
1.91
4.31
0.97
3.08
1.03
1.09
1.02
0.88
0.94
0.96
2.47
dm
so2.
48 d
mso
2.49
2.50
2.51
3.28
3.29
3.33
HD
O3.
563.
573.
583.
59
7.37
7.37
7.39
7.39
7.41
7.41
7.55
7.56
7.56
7.60
7.62
7.64
7.64
7.79
7.80
7.82
7.82
7.92
7.92
7.93
7.94
7.95
7.96
8.21
8.22
8.22
8.23
8.38
10.4
510
.46
12.0
7
Page 4
0102030405060708090100110120130140150160170180f1 (ppm)
39.2
8 dm
so39
.49
dmso
39.7
0 dm
so39
.91
dmso
40.1
2 dm
so40
.32
dmso
40.5
3 dm
so
53.3
9
60.8
0
66.5
8
108.
85
118.
4912
0.41
121.
94
128.
5212
9.48
130.
0413
1.23
131.
7313
4.85
135.
1413
5.53
139.
55
149.
11
157.
90
163.
56
168.
98
2,4-dichloro-N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)benzamide 5c:
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.011.512.012.513.0f1 (ppm)
3.89
2.16
4.10
1.07
1.03
2.19
2.07
0.82
0.63
0.99
1.05
2.52
dm
so2.
52 d
mso
2.53
dm
so2.
53 d
mso
2.54
2.55
2.56
3.34
3.41
HD
O3.
623.
633.
64
7.41
7.43
7.45
7.52
7.53
7.54
7.55
7.58
7.59
7.60
7.61
7.66
7.67
7.68
7.69
7.81
7.81
8.42
8.43
8.43
10.6
6
12.1
6
Page 5
0102030405060708090100110120130140150160170180f1 (ppm)
39.2
5 dm
so39
.46
dmso
39.6
7 dm
so39
.88
dmso
40.0
9 dm
so40
.30
dmso
40.5
0 dm
so
53.3
7
60.7
7
66.5
7
108.
94
117.
5911
9.60
121.
90
127.
9212
9.60
129.
6413
0.77
131.
6513
5.28
136.
1513
9.53
149.
06
157.
92
164.
49
168.
98
3-chloro-N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)benzamide 5d:
Page 6
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.011.512.012.513.0f1 (ppm)
4.06
2.06
4.21
0.99
5.10
1.02
0.89
0.83
0.90
0.94
2.47
dm
so2.
48 d
mso
2.49
2.50
3.29
3.35
HD
O3.
563.
573.
583.
59
7.36
7.38
7.39
7.40
7.41
7.53
7.55
7.56
7.61
7.63
7.66
7.90
7.92
7.93
8.01
8.39
10.4
110
.42
12.0
7
Page 7
3-bromo-N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)benzamide 5e:
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.011.512.012.513.0f1 (ppm)
3.41
2.20
3.72
1.09
1.48
3.12
1.97
1.04
0.91
0.91
1.15
2.53
dm
so2.
56
3.34
3.35
3.41
HD
O3.
63
7.42
7.43
7.45
7.47
7.61
7.67
7.69
7.92
7.95
7.97
7.98
8.07
8.45
10.4
7
12.1
3
Page 8
0102030405060708090100110120130140150160170180f1 (ppm)
39.2
6 dm
so39
.47
dmso
39.6
8 dm
so39
.89
dmso
40.1
0 dm
so40
.31
dmso
40.5
2 dm
so
53.3
9
60.7
9
66.5
7
108.
81
118.
4712
0.41
121.
83
126.
9512
7.84
129.
4413
0.89
131.
8913
3.64
135.
1113
7.22
139.
68
149.
15
157.
89
164.
47
168.
98
4-fluoro-N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)benzamide 5g:
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.011.512.0f1 (ppm)
4.17
1.89
4.25
3.04
0.78
2.21
1.92
0.85
0.92
0.97
2.47
dm
so2.
47 d
mso
2.48
dm
so2.
492.
503.
283.
293.
35 H
DO
3.56
3.57
3.58
3.59
7.33
7.33
7.34
7.35
7.35
7.36
7.37
7.38
7.39
7.40
7.55
7.55
7.60
7.62
8.01
8.02
8.03
8.04
8.05
8.06
8.38
8.39
10.3
310
.34
12.0
7
Page 9
0102030405060708090100110120130140150160170180f1 (ppm)
39.2
6 dm
so39
.47
dmso
39.6
8 dm
so39
.89
dmso
40.1
0 dm
so40
.31
dmso
40.5
2 dm
so
53.3
9
60.8
0
66.5
8
108.
77
115.
6911
5.91
118.
4712
0.40
121.
66
129.
4113
0.80
130.
8913
1.67
131.
7013
5.09
139.
86
149.
20
157.
88
163.
2816
4.84
165.
7616
8.98
3-fluoro-N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)benzamide 5h:
Page 10
N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)-3-(trifluoromethyl)benzamide
5i:
Page 11
0102030405060708090100110120130140150160170180f1 (ppm)
39.2
6 dm
so39
.47
dmso
39.6
8 dm
so39
.89
dmso
40.1
0 dm
so40
.31
dmso
40.5
2 dm
so
53.3
9
60.8
0
66.5
7
108.
84
118.
5912
0.50
121.
9212
4.64
124.
6812
8.65
129.
4812
9.75
130.
2213
0.50
132.
3413
3.65
135.
1413
6.10
139.
61
149.
11
157.
90
164.
43
168.
98
N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)-4-(trifluoromethyl)benzamide
Page 12
5j:
0102030405060708090100110120130140150160170180f1 (ppm)
39.2
6 dm
so39
.46
dmso
39.6
7 dm
so39
.88
dmso
40.0
9 dm
so40
.30
dmso
40.5
1 dm
so
53.3
9
60.8
4
66.5
8
108.
80
118.
5212
0.46
121.
9212
3.00
124.
5212
5.71
125.
7912
5.83
125.
8712
5.90
129.
0712
9.46
129.
9413
1.64
131.
9513
5.16
139.
0813
9.64
149.
11
158.
03
164.
82
169.
05
Page 13
N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)furan-2-carboxamide 5k:
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.011.512.012.513.0f1 (ppm)
4.13
2.06
4.09
0.93
1.10
0.82
1.04
1.07
0.93
0.84
0.98
0.99
1.02
2.51
dm
so2.
51 d
mso
2.51
dm
so2.
52 d
mso
2.52
dm
so2.
532.
542.
553.
333.
37 H
DO
3.61
3.62
3.63
6.73
6.73
6.73
6.74
7.38
7.39
7.41
7.43
7.59
7.63
7.63
7.64
7.65
7.65
7.66
7.97
7.97
8.38
8.39
8.39
10.2
9
12.1
2
Page 14
0102030405060708090100110120130140150160170180f1 (ppm)
34.6
8 dm
so34
.89
dmso
35.1
0 dm
so35
.31
dmso
35.5
2 dm
so35
.72
dmso
35.9
3 dm
so
48.7
9
56.2
0
61.9
8
104.
1910
8.01
110.
6111
3.84
115.
7711
7.05
124.
83
130.
50
134.
73
141.
6514
3.27
144.
56
152.
0515
3.28
164.
37
2-methoxy-N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)acetamide 5l:
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.011.512.012.513.0f1 (ppm)
10.7
3
2.10
2.11
1.03
1.21
0.97
1.20
0.92
0.73
1.00
2.47
dm
so
3.35
3.35
3.36
HD
O3.
983.
994.
144.
14
7.30
7.30
7.32
7.32
7.34
7.35
7.48
7.50
7.52
7.53
7.55
7.57
8.27
9.79
12.2
2
Page 15
0102030405060708090100110120130140150160170180f1 (ppm)
39.2
6 dm
so39
.47
dmso
39.6
8 dm
so39
.88
dmso
40.0
9 dm
so40
.30
dmso
40.5
1 dm
so
59.0
959
.18
70.8
672
.09
108.
80
117.
8111
9.78
121.
48
129.
42
135.
08
139.
21
149.
19
157.
75
168.
5516
9.04
N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)cyclohexanecarboxamide 5m:
Page 16
0102030405060708090100110120130140150160170180f1 (ppm)
21.0
721
.24
24.9
834
.68
dmso
34.8
9 dm
so35
.10
dmso
35.3
0 dm
so35
.51
dmso
35.7
2 dm
so35
.93
dmso
40.6
4
48.7
8
56.1
8
61.9
6
104.
01
112.
6111
4.42
114.
8811
6.20
121.
88
124.
76
130.
45
135.
67
144.
69
153.
20
164.
31
170.
16
N-(4-(3-acetamidophenyl)thiazol-2-yl)-2-morpholinoacetamide 5n:
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.511.011.512.012.513.0f1 (ppm)
2.95
3.98
2.11
4.13
0.96
1.05
1.96
0.97
0.89
1.01
2.02
2.02
2.03
2.46
dm
so2.
47 d
mso
2.47
dm
so2.
482.
482.
492.
492.
502.
503.
273.
283.
283.
33 H
DO
3.34
HD
O3.
34 H
DO
3.56
3.56
3.57
3.58
3.58
7.27
7.28
7.28
7.29
7.29
7.30
7.31
7.31
7.32
7.39
7.41
7.49
7.50
7.50
7.52
7.52
7.53
8.17
8.18
8.18
8.19
9.99
10.0
1
12.0
6
Page 17
2-chloro-N-(3-(2-(2-morpholinoacetamido)thiazol-4-yl)phenyl)acetamide 5o:
Page 18
0102030405060708090100110120130140150160170180f1 (ppm)
39.2
6 dm
so39
.47
dmso
39.5
539
.67
dmso
39.8
8 dm
so40
.09
dmso
40.3
0 dm
so40
.51
dmso
44.0
5
53.3
5
60.6
8
66.4
8
108.
96
117.
3911
9.30
121.
72
126.
66
129.
66
135.
25
139.
27
148.
98
157.
87
165.
12